In The News Posted July 8, 2019 Share Posted July 8, 2019 CAMBRIDGE, England, July 8, 2019 /PRNewswire/ -- NeoPhore Limited, a small molecule cancer immuno-oncology company, today announces the appointment of Dr Matthew Baker as VP Immunology to the company's management team. Dr Baker has more than 15 years' experience developing biologics in... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.